Clinical trial Recruiting at 1 site Interventional Ages 16 to 55 Women only

Integrated maternity care model to reduce severe maternal morbidity in BIPOC patients

Official title: The ENHANCED Trial: Enriched Holistic Care to Eradicate Disparities in Maternal Morbidity

Run by University of Pennsylvania · NCT06245057 · Data updated 2026-11-12

This study is testing a new maternity care model that combines prenatal care with social services to see if it can help reduce serious health problems for Black, Indigenous, and people of color during and after pregnancy.

More Perinatal Depression trials

Quick facts

Study typeInterventional
Ages16 Years to 55 Years
SexWomen only
Enrollment2300 (estimated)
SponsorUniversity of Pennsylvania
Academic / other
Locations2 sites (Phialdelphia, Pennsylvania and 1 other locations)
StatusRecruiting
StartedJanuary 30, 2024
Main results expectedJanuary 31, 2028
Study endsJanuary 31, 2028
Registry record updatedApril 21, 2026
Trial IDNCT06245057 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates are pregnant individuals aged 16-55 who self-identify as Black, Indigenous, Asian, or Latina and plan to deliver at the participating hospitals.

Probably not a fit

Patients who are unable to provide written consent or are already enrolled in a similar maternity care model will not benefit from this study.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This randomized controlled intervention evaluates a comprehensive maternity care home model (MCHM) designed to reduce severe maternal morbidity (SMM) among Black, Indigenous, and people of color (BIPOC) patients. The study compares the MCHM, which integrates prenatal care with social services, to standard care that relies on outsourced social service referrals. Participants will be followed throughout their pregnancy and up to one year postpartum to assess the effectiveness of this integrated approach in addressing social and structural inequities. The trial aims to provide a holistic solution to the disparities faced by vulnerable populations in maternal health.

Why it matters

Potential benefit: If successful, this approach could significantly reduce severe maternal morbidity and improve health outcomes for BIPOC patients during and after pregnancy.

How similar studies have gone: While previous studies have explored single social determinants, this integrated approach is novel and aims to comprehensively address multiple factors affecting maternal health disparities.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Pregnant patients who self-identify as Black, Indigenous, Asian, or Latina (BIPOC)
* Ages 16-55
* Presentation to the hospital in pregnancy - this includes prenatal care or the emergency department
* Plan to deliver at the 2 Penn hospital sites
* Patients must be able to read and understand English or Spanish
* Participants must be willing and able to sign the informed consent form

Exclusion Criteria:

* Unable to provide written consent by being unable to read or sign informed consent.
* Enrolled in ENHANCED Trial in a prior pregnancy
* Already participating in Maternity Care Home Model (MCHM)

Where it's running

  • Hospital of the University of Pennsylvania
    Phialdelphia, Pennsylvania, United States
    Recruiting
  • Pennsylvania Hospital
    Philadelphia, Pennsylvania, United States
    Not yet recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.